Back to Investors
BI

BBB Investments

Venture Capital

Portfolio

1

companies


Portfolio companies

1nhaler

1nhaler

Developer of a novel paper-based dry powder inhaler platform.


Recent investments

Seed
£1.5M

The financing will support clinical material manufacture and preparation for regulatory studies ahead of a target marketing authorisation application.

"This additional funding represents strong continued confidence in our technology platform and our progress towards commercialisation. The support from Archangels, Scottish Enterprise and BBB Investments is enabling us to advance our clinical and manufacturing capabilities as we work towards regulatory approval."
— Lisa McMyn, Chief Executive Officer